These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6212602

  • 21. Propionibacterium acnes resistance to antibiotics in acne patients.
    Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM.
    J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134
    [Abstract] [Full Text] [Related]

  • 22. Antibiotic susceptibility of Propionibacterium acnes isolated from patients with acne in a public hospital in Southwest China: prospective cross-sectional study.
    Zhu T, Zhu W, Wang Q, He L, Wu W, Liu J, Li Y, Sun D.
    BMJ Open; 2019 Feb 19; 9(2):e022938. PubMed ID: 30782869
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
    Puhvel SM.
    Cutis; 1983 Mar 19; 31(3):339-42. PubMed ID: 6220870
    [Abstract] [Full Text] [Related]

  • 25. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
    Akamatsu H, Nishijima S, Takahashi M, Ushijima T, Asada Y.
    J Dermatol; 1991 May 19; 18(5):247-51. PubMed ID: 1834712
    [Abstract] [Full Text] [Related]

  • 26. Effects of topical erythromycin on aerobic and anaerobic surface flora.
    Bernstein JE, Shalita AR.
    Acta Derm Venereol; 1980 May 19; 60(6):537-9. PubMed ID: 6162344
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Ad Hoc Committee report: systemic antibiotics for treatment of acne vulgaris: efficacy and safety.
    Arch Dermatol; 1975 Dec 19; 111(12):1630-6. PubMed ID: 128326
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines.
    Del Rosso JQ.
    Cutis; 2004 Aug 19; 74(2):118-22. PubMed ID: 15379364
    [No Abstract] [Full Text] [Related]

  • 35. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M, Lamerz A, Franke-Hoffman M.
    Zentralbl Bakteriol A; 1981 Feb 19; 248(4):502-8. PubMed ID: 6452774
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L, Grootveld M, Arroo R, Ruiz-Rodado V, Price P, Laird K.
    Phytother Res; 2017 Mar 19; 31(3):410-417. PubMed ID: 28124400
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bacterial resistance in French acne patients.
    Dumont-Wallon G, Moyse D, Blouin E, Dréno B.
    Int J Dermatol; 2010 Mar 19; 49(3):283-8. PubMed ID: 20465665
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.